# Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

> **NCT00801151** · PHASE1 · TERMINATED · sponsor: **Institut Claudius Regaud** · enrollment: 30 (estimated)

## Conditions studied

- Malignant Solid Tumour

## Interventions

- **DRUG:** Zolinza (vorinostat), vinorelbine

## Key facts

- **NCT ID:** NCT00801151
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2009-10
- **Final completion:** 2009-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00801151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00801151, "Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00801151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*